The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human, multicenter phase Ⅰ study of TGRX-326 in patients with advanced ALK-positive non-small cell lung cancer.
 
Hongyun Zhao
No Relationships to Disclose
 
Yuxiang Ma
No Relationships to Disclose
 
Nong Yang
No Relationships to Disclose
 
Zhehai Wang
No Relationships to Disclose
 
Wenjian Jin
No Relationships to Disclose
 
Xingya Li
No Relationships to Disclose
 
Yunpeng Liu
No Relationships to Disclose
 
Rui Meng
No Relationships to Disclose
 
Jianying Zhou
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Yongsheng Wang
No Relationships to Disclose
 
Zhuang Yu
No Relationships to Disclose
 
Li Zhang
Consulting or Advisory Role - AstraZeneca; Innovent Biologics
Speakers' Bureau - AstraZeneca; BeiGene; HenRui; Innovent Biologics; Roche China
Research Funding - Akeso Biopharma (Inst); AstraZeneca (Inst); BMS (Inst); Chia Tai Tianqing Pharmaceutical Group (Inst); Junshi Pharmaceuticals (Inst); QiLu Pharmaceutical (Inst)